This content is machine translated Uncontrolled type 2 diabetes Empagliflozin as an effective addition to triple therapies In patients with type 2 diabetes (T2D), a balanced glucose concentration is mainly achieved through drug therapies. If blood glucose control remains poor despite a triple combination of oral hypoglycaemic...…
View Post 4 min This content is machine translated Pharmacotherapy for people over 80 A case of age discrimination? SGLT2 inhibitors and GLP1 receptor agonists have emerged as the drugs of first choice in the guidelines for type 2 diabetes. Sulfonylureas and insulin, on the other hand, were deprioritized…
View Post 4 min This content is machine translated AID systems Improved therapy for type 1 diabetes with new devices Increasingly, AID (Automated Insulin Delivery) systems are being used for automated or semi-automated insulin dosing in the treatment of type 1 diabetes. Through pump and sensor technology coupled with control…
View Post 4 min This content is machine translated GLP-1 receptor agonists Jack of all trades in the fight against type 2 diabetes GLP-1 receptor agonists (RA) have been used in the treatment of diabetic patients since 2005. For patients, their introduction was a milestone, as GLP-1 RAs have the great advantage of…
View Post 5 min This content is machine translated Medidays Zurich 2017 Diabetes mellitus type 2 – Targeted through the drug jungle The number of people suffering from diabetes continues to rise. According to an estimate by the International Diabetes Federation, approximately 592 million people will be affected in 2035. This disease,…
View Post 3 min This content is machine translated Alcohol Emergencies Do not forget the background of intoxications In recent decades, alcohol consumption in Switzerland has decreased overall – but at the same time, the number of people who are hospitalized in emergency due to alcohol intoxication is…
View Post 3 min This content is machine translated Diabetes Day in Bern New insulins improve compliance and reduce the risk of hypoglycemia Several new diabetes drugs have come on the market in recent months. It is becoming increasingly difficult for primary care providers to maintain an overview in the “jungle” of diabetes…
View Post 9 min This content is machine translated New antidiabetic agents Combination therapies enable very potent HbA1c reduction Lifestyle modification (exercise, diet) and metformin remain the cornerstones in the treatment of diabetes mellitus type 2. Before initiating antidiabetic therapy, it is recommended to set an individual HbA1c target. Advantages…
View Post 3 min This content is machine translated Type 2 diabetes SGLT-2 inhibitors: a new oral therapy option Dapagliflozin, a potent new selective SGLT-2 inhibitor, is available in many countries for use in type 2 diabetes patients either as add-on combination therapy when other glucose-lowering medical agents together…
View Post 8 min This content is machine translated Insulin in type 2 diabetes When and in which combination? The current therapy guidelines for diabetes mellitus type 2 provide for the use of insulin as initial therapy as well as a later therapy option in monotherapy or in combination with…
View Post 5 min This content is machine translated News about acne and acne inversa “Milk lie” and low-dose isotretinoin The majority of this year’s Zurich Dermatological Training Days was devoted to skin appendages. For the topics “News on Acne” and “Acne inversa”, Prof. Dr. med. Martin Schaller from Tübingen,…
